Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study.

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study.

This examine examined the affiliation between peritoneal cytology and survival in early-stage cervical most cancers. This is a nationwide multicenter retrospective examine, analyzing consecutive girls with scientific stage IB1-IIB cervical most cancers who underwent radical hysterectomy with obtainable peritoneal cytology outcomes from 2004-2008.

Propensity rating inverse likelihood of therapy weighting was used to evaluate the influence of malignant peritoneal cytology on survival. Among 1409 analyzed circumstances, 88 (6.2%) had malignant peritoneal cytology. On weighted fashions, malignant peritoneal cytology was related with decreased disease-free survival (hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.36-2.32) and total survival (OS, HR 1.93, 95% CI 1.44-2.59).

On sensitivity analyses, malignant peritoneal cytology was related with decreased OS in adenocarcinoma/adenosquamous carcinoma, high-risk early-stage illness and those that acquired concurrent chemo-radiotherapy. However, amongst girls who acquired postoperative systemic chemotherapy, malignant peritoneal cytology was not related with OS (HR 1.21, 95% CI 0.72-2.04).

A systematic evaluation, together with our outcomes, confirmed that malignant peritoneal cytology was related with decreased OS (HR 4.03, 95% CI 1.81-8.99) and elevated recurrence in squamous carcinoma (odds ratio 1.89, 95% CI 1.05-3.39) and adenocarcinoma (odds ratio 4.30, 95% CI 2.30-8.02). In conclusion, the presence of malignant cells in peritoneal cytology is related with decreased survival in early-stage cervical most cancers. The doable profit of systemic chemotherapy on this subgroup deserves additional investigation.

Although the charges are usually low (0.2%-10%), unsatisfactory Papanicolaou (Pap) checks are related with an elevated danger of epithelial lesions on subsequent follow-up. Therefore, some research have advisable further laboratory processing, resampling of sufferers, and extra not too long ago, human papillomavirus testing.Consecutive circumstances signed out as unsatisfactory for analysis (UE) have been recognized from January 1, 2008 to December 31, 2010 in the cytology laboratory at Houston Methodist Hospital.

Patient’s demographics, related prior scientific historical past, kind of Pap check, causes for UE prognosis, and cytology or histology follow-up have been obtained from the pathology database.Among 56,563 complete Pap checks, 276 have been signed out as UE (0.47%). Nearly half of these sufferers have been older than 50 years (15 to 88 years). The majority (85%) of sufferers over 50 years outdated had a historical past of prior gynecologic most cancers. Low squamous cellularity was the commonest trigger of UE in all age teams.

Follow-up abnormalities have been recognized in 21 of 73 sufferers (29%).Low squamous cellularity was the commonest trigger of UE and was typically seen in girls older than 50 years of age.The common rating for the first check set was considerably greater for residents who acquired formal coaching by a cytotechnologist than for many who didn’t. Overall, 16 of 90 slides have been misclassified by 40% or extra of residents, half of which exhibited glandular abnormalities.The goal evaluation offered by mock PT is a great tool for each college and residents.

Mock gynecologic cytology proficiency testing as a milestone evaluation device for anatomic pathology residents.

One of the main goals of the Next Accreditation System is to maneuver towards an outcomes-based analysis system the place every accredited medical residency program should exhibit that its residents are competent in performing the important duties needed for scientific follow. The vital danger related with UE emphasizes the significance of acceptable follow-up on these sufferers.

Because all pathologists who sign-out or display screen Papanicolaou (Pap) checks are required to move an annual 10-slide gynecologic cytology proficiency check (PT), we developed mock PT modules as a device for assessing competency.In 2007, we launched mock proficiency testing with Three distinct modules, every consisting of 3 10-slide check units (10 ThinPrep, 10 SurePath, and 10 standard Pap slides).

Each module was administered at Three completely different time factors. We evaluated the following parameters: (1) efficiency variations between Pap preparations; (2) efficiency over time; (3) efficiency earlier than and after initiation of one-on-one instructing periods with cytotechnologists in 2009; and (4) high quality of check slides.Residents confirmed enchancment over time, and total scores didn’t differ considerably amongst ThinPrep, SurePath, and traditional slide units.

Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study.

Pancreatobiliary duct brushing cytopathology: an evaluation of the CAP Non-Gynecologic Cytology (NGC) program for pancreatic pathology 2000-2011.

<AbstractText>The College of American Pathologists (CAP, Northfield, Illinois) displays efficiency in cytologic evaluation to guage the commonplace of follow and take into account methods for methodology enchancment.</AbstractText><AbstractText>5700 responses to 97 pancreatobiliary tract brushing slide challenges have been collected by the CAP Non-Gynecologic Cytopathology (NGC) Program, between 2000 and 2011.

Analysis examined participant settlement with the common diagnostic classes of benign or malignant. Suspicious responses have been categorised as concordant with slides having a optimistic common prognosis. Conventional smears with Pap stain and Romanowsky stain have been evaluated along with CytoSpin, ThinPrep, and SurePath preparations. ThinPrep, or SurePath.</AbstractText><AbstractText>Participants carried out properly with better than 90% settlement with the goal diagnostic class.

A nonlinear combined mannequin was match with Three factors-general prognosis, participant kind, and preparation kind.</AbstractText><AbstractText>Overall concordance price was 91.7%. Preparation kind and common prognosis have been considerably related with the concordance price. The interplay time period between these two elements was additionally statistically vital, with ThinPrep performing marginally higher for optimistic circumstances and CytoSpin performing higher for detrimental circumstances. Conventional smears didn’t carry out in addition to CytoSpin,

Wright-Giemsa Stain Kit

K1438-500
EUR 370

Wright-Giemsa Stain Kit

WGK-1 1 kit(s)
EUR 116

Wright-Giemsa Stain Kit

WGK-2 1 kit(s)
EUR 84

Holder for Plasmid Midi, Maxi and Maxi plus, Ion Exchange column

FAPDE-holder-for-ion-exchange 1 prep
EUR 158

Sample comb for batching for AE-6110

2398313 unit
EUR 100
Description: (90mm・r efer ence at t ached・1.5mm t i ck ness)

Adaptor for flexible plates, accessory for AgileSealer?

APS-200-FP
EUR 351

For-Ala-OH

5-02335 25g Ask for price

For-Ala-OH

5-02336 100g Ask for price

For-Val-OH

5-03697 25g Ask for price

For-Val-OH

5-03698 100g Ask for price

I.S. for Haloperidol

50R-R1854 50 mg
EUR 241
Description: Haloperidol chemical reference substance

TMB for Microarrays

42R-1004 500 ml
EUR 354
Description: Ultra sensitive TMB Peroxidase Substrate ready to use in immunoarrays.

pNPP for ELISA

42R-1005 500 ml
EUR 354

TMB for Precipitation

42R-TB100x 1000 ml
EUR 538
Description: High sensitivity TMB Substrate for Precipitation assays

TMB for Histochemistry

42R-TB103 500 ml
EUR 327
Description: High sensitivity TMB Substrate for Histochemistry assays

For-Ala-OMe

E-1845.0005 5.0g
EUR 200
Description: Sum Formula: C5H9NO3; CAS# [32221-83-3]

For-Ala-OMe

E-1845.0025 25.0g
EUR 708
Description: Sum Formula: C5H9NO3; CAS# [32221-83-3]

For-Met-OH

E-1850.0005 5.0g
EUR 126
Description: Sum Formula: C6H11NO3S; CAS# [4289-98-9]

For-Met-OH

E-1850.0025 25.0g
EUR 418
Description: Sum Formula: C6H11NO3S; CAS# [4289-98-9]

For-Val-OH

E-1855.0005 5.0g
EUR 115
Description: Sum Formula: C6H11NO3; CAS# [4289-97-8]

For-Val-OH

E-1855.0025 25.0g
EUR 357
Description: Sum Formula: C6H11NO3; CAS# [4289-97-8]

For-Phe-OH

E-2690.0005 5.0g
EUR 115
Description: Sum Formula: C10H11NO3; CAS# [13200-85-6]

For-Phe-OH

E-2690.0025 25.0g
EUR 321
Description: Sum Formula: C10H11NO3; CAS# [13200-85-6]

For-Phe-OMe

E-2825.0005 5.0g
EUR 115
Description: Sum Formula: C11H13NO3; CAS# [2311-21-9]

For-Phe-OMe

E-2825.0025 25.0g
EUR 309
Description: Sum Formula: C11H13NO3; CAS# [2311-21-9]

Stand for D1000

D1000-ST 1 PC
EUR 558.29

Hematoxylin, For Automation

HAQ500 500 ml
EUR 71

Hematoxylin, For Automation

HAQ999 1000 ml
EUR 85

gelcaster for sequencer

ESEQ1000-CAST ea
EUR 437

Stand for D1000

BCM1237 1 pcs, 1 UNIT
EUR 556.7

Antibody for KDEL

SPC-109A 0.05mg
EUR 205
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is unconjugated.

Antibody for KDEL

SPC-109B 0.2mg
EUR 350
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is unconjugated.

Antibody for KDEL

SPC-109B-A390 0.2mg
EUR 439
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 390.

Antibody for KDEL

SPC-109B-A488 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 488.

Antibody for KDEL

SPC-109B-A565 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 565.

Antibody for KDEL

SPC-109B-A594 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 594.

Antibody for KDEL

SPC-109B-A633 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 633.

Antibody for KDEL

SPC-109B-A655 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 655.

Antibody for KDEL

SPC-109B-A680 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 680.

Antibody for KDEL

SPC-109B-A700 0.2mg
EUR 436
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to ATTO 700.

Antibody for KDEL

SPC-109B-ALP 0.2mg
EUR 425
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Alkaline Phosphatase.

Antibody for KDEL

SPC-109B-APC 0.2mg
EUR 435
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to APC .

Antibody for KDEL

SPC-109B-APCCY7 0.2mg
EUR 585
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to APC/Cy7.

Antibody for KDEL

SPC-109B-BI 0.2mg
EUR 427
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Biotin.

Antibody for KDEL

SPC-109B-DY350 0.2mg
EUR 471
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Dylight 350.

Antibody for KDEL

SPC-109B-DY405 0.2mg
EUR 448
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Dylight 405.

Antibody for KDEL

SPC-109B-DY488 0.2mg
EUR 428
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Dylight 488.

Antibody for KDEL

SPC-109B-DY594 0.2mg
EUR 432
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Dylight 594.

Antibody for KDEL

SPC-109B-DY633 0.2mg
EUR 422
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Dylight 633.

Antibody for KDEL

SPC-109B-FITC 0.2mg
EUR 420
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to FITC.

Antibody for KDEL

SPC-109B-HRP 0.2mg
EUR 414
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to HRP.

Antibody for KDEL

SPC-109B-P594 0.2mg
EUR 447
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to PE/ATTO 594.

Antibody for KDEL

SPC-109B-PCP 0.2mg
EUR 435
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to PerCP.

Antibody for KDEL

SPC-109B-RPE 0.2mg
EUR 429
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to RPE .

Antibody for KDEL

SPC-109B-STR 0.2mg
EUR 432
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is conjugated to Streptavidin.

Antibody for KDEL

SPC-109S 0.012mg
EUR 65
Description: A polyclonal antibody for KDEL from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with KDEL containing peptide immunogen. The Antibody is tested and validated for WB, ICC/IF, IHC assays with the following recommended dilutions: WB (1:1000), ICC/IF (1:100). This KDEL antibody is unconjugated.

Antibody for CD9

SPC-1272D 0.1ml
EUR 314
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is unconjugated.

Antibody for CD9

SPC-1272D-A390 0.1ml
EUR 361
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 390.

Antibody for CD9

SPC-1272D-A488 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 488.

Antibody for CD9

SPC-1272D-A565 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 565.

Antibody for CD9

SPC-1272D-A594 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 594.

Antibody for CD9

SPC-1272D-A633 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 633.

Antibody for CD9

SPC-1272D-A655 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 655.

Antibody for CD9

SPC-1272D-A680 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 680.

Antibody for CD9

SPC-1272D-A700 0.1ml
EUR 360
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to ATTO 700.

Antibody for CD9

SPC-1272D-ALP 0.1ml
EUR 355
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Alkaline Phosphatase.

Antibody for CD9

SPC-1272D-APC 0.1ml
EUR 359
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to APC .

Antibody for CD9

SPC-1272D-APCCY7 0.1ml
EUR 432
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to APC/Cy7.

Antibody for CD9

SPC-1272D-BI 0.1ml
EUR 357
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Biotin.

Antibody for CD9

SPC-1272D-DY350 0.1ml
EUR 436
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 350.

Antibody for CD9

SPC-1272D-DY405 0.1ml
EUR 412
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 405.

Antibody for CD9

SPC-1272D-DY488 0.1ml
EUR 393
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 488.

Antibody for CD9

SPC-1272D-DY594 0.1ml
EUR 397
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 594.

Antibody for CD9

SPC-1272D-DY633 0.1ml
EUR 387
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Dylight 633.

Antibody for CD9

SPC-1272D-FITC 0.1ml
EUR 353
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to FITC.

Antibody for CD9

SPC-1272D-HRP 0.1ml
EUR 349
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to HRP.

Antibody for CD9

SPC-1272D-P594 0.1ml
EUR 367
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to PE/ATTO 594.

Antibody for CD9

SPC-1272D-PCP 0.1ml
EUR 359
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to PerCP.

Antibody for CD9

SPC-1272D-RPE 0.1ml
EUR 358
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to RPE .

Antibody for CD9

SPC-1272D-STR 0.1ml
EUR 359
Description: A polyclonal antibody for CD9 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with A synthesized peptide. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:200), ICC/IF (1:200). This CD9 antibody is conjugated to Streptavidin.

Antibody for Phosphoserine

SPC-149F 0.4ml
EUR 362
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is unconjugated.

Antibody for Phosphoserine

SPC-149F-A390 0.4ml
EUR 409
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 390.

Antibody for Phosphoserine

SPC-149F-A488 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 488.

Antibody for Phosphoserine

SPC-149F-A565 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 565.

Antibody for Phosphoserine

SPC-149F-A594 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 594.

Antibody for Phosphoserine

SPC-149F-A633 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 633.

Antibody for Phosphoserine

SPC-149F-A655 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 655.

Antibody for Phosphoserine

SPC-149F-A680 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 680.

Antibody for Phosphoserine

SPC-149F-A700 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to ATTO 700.

Antibody for Phosphoserine

SPC-149F-ALP 0.4ml
EUR 403
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to Alkaline Phosphatase.

Antibody for Phosphoserine

SPC-149F-APC 0.4ml
EUR 408
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to APC .

Antibody for Phosphoserine

SPC-149F-APCCY7 0.4ml
EUR 480
Description: A polyclonal antibody for Phosphoserine from Species Independent. The antibody is produced in rabbit after immunization with Phosphoserine conjugated to KLH, and phosvitin mixture. The Antibody is tested and validated for WB, IHC, ICC/IF, IP, ELISA assays with the following recommended dilutions: WB (1:500), ICC/IF (1:50), ELISA (1:250), IP (1:100). This Phosphoserine antibody is conjugated to APC/Cy7.

There was no vital distinction between cytotechnologists and pathologists. Small vital variations have been discovered between preparations sorts. The statistical variations between focus methods could also be attributable to dissimilarities in the amount of cells and high quality of cytomorphology, thus affecting the interpretations by taking part laboratories.</AbstractText>

Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.

Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
Cervical cancer is one of the widespread cancers in girls accounting for 7.9% of all cancers. In India it’s the second commonest cancer in girls. The immortality of the cancer cell and the comparatively lengthy timeframe from acquisition of an infection to growth of cervical cancer was established.
As main developments like LBC, HPV testing have been launched within the current years, screening has taken a brand new avatar, the Molecular pap!! The goals of this research have been: To evaluate gynecologic cytology and irregular outcomes with respect to standard and LBC. To research the function of HPV cotesting and ancillary checks carried out, that’s, HPV CISH, and p16ink4a by IHC.
About 71 924 Conventional and LBC samples have been included from August 2009 to December 2017. Cases for HPV testing alongside the traditional smears have been 1539. HPV could be examined from the identical LBC vial because the pattern stays steady at room temperature for six weeks. HPV DNA PCR was carried out in our laboratory for High and Low danger genotypes.
Cytology findings have been additionally correlated with histology. Detection charge of SILs in LBC samples have been greater (2.20%). The commonest abnormality was LSIL in LBC and ASCUS in typical smears. LBC with HPV cotesting improves sensitivity and specificity and reduces ambiguous outcomes; permits higher compliance, as a adverse outcome of each checks permits sufferers to get screening each 5 years, thereby rising screening intervals, essential in a useful resource restricted state of affairs.

Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A observe survey of contributors within the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program.

Intra-procedural evaluation of contact imprint (TI) cytology from needle core biopsies (NCB) is used to make sure pattern adequacy and to offer rapid prognosis in numerous settings. We aimed to survey laboratories for present practices on the use of cytology with NCB. A voluntary supplemental questionnaire together with questions on demographics, personnel concerned, websites, accessioning, and reporting was despatched with the College of American Pathologists (CAP) 2015 Non gynecologic Cytopathology Education Program to survey practices of cytologic evaluation of NCB.
Among 844 respondents, 403 (48%) carried out cytologic evaluation of NCB. Common physique websites included lung (94%; 368/392), liver (87%; 340/ 392), and lymph nodes/spleen (77%; 303/392). Most of the time, a pathologist was current on-site 75% (295/393) for adequacy evaluation which was often verbally reported to the supplier performing the process.
Specimens have been ready by cytotechnologists (50%; 193 of 388) or pathologists (45%; 176 of 388) by touching the core to the slide (50%; 196 of 390) and rolling the core on the slide (45%; 177/390). Among the respondents, 19% stated that cytotechnologists independently carried out rapid evaluation of TI of NCB. Most laboratories (69%; 264/384) evaluated air-dried slides with a modified Giemsa stain and rendered one TI/NCB mixed report (87%, 334/385).
Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient inhabitants.

Women who check optimistic for a high-risk sort of the human papillomavirus (HPV) require triage testing to determine these girls with cervical intraepithelial neoplasia grade Three or cancer (≥CIN3). Although Pap cytology is taken into account a gorgeous triage check, its applicability is hampered by its subjective nature. This research prospectively in contrast the scientific efficiency of p16/Ki-67 dual-stained cytology to that of Pap cytology, with or with out HPV16/18 genotyping, in high-risk HPV-positive girls visiting gynecologic outpatient clinics (n=446 and age 18-66 years).

From all girls, cervical scrapes (for Pap cytology, HPV16/18 genotyping, and p16/Ki-67 dual-stained cytology) and colposcopy-directed biopsies have been obtained. This is the primary survey carried out particularly to find out the observe of adequacy evaluation of TI of NCB. Cytotechnologists are usually not performing adequacy evaluation of TI with out pathologist oversight. A single report is often issued which incorporates the adequacy evaluation as a component of the ultimate report.

The sensitivity of p16/Ki-67 dual-stained cytology for ≥CIN3 (93.8%) did neither differ considerably from that of Pap cytology (87.7%; ratio 1.07 and 95% confidence interval (CI): 0.97-1.18) nor from that of Pap cytology mixed with HPV16/18 genotyping (95.1%; ratio 0.99 and 95% CI: 0.91-1.07). However, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (51.2%) was considerably greater than that of Pap cytology (44.9%; ratio 1.14 and 95% CI: 1.01-1.29) and Pap cytology mixed with HPV16/18 genotyping (25.8%; ratio 1.99 and 95% CI: 1.68-2.35).

After exclusion of girls who had been referred as a result of of irregular Pap cytology, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (56.7%) remained the identical, whereas that of Pap cytology (60.3%) elevated considerably, leading to the same specificity of each assays (ratio 0.94 and 95% CI: 0.83-1.07) on this sub-cohort. In abstract, p16/Ki-67 dual-stained cytology has a superb scientific efficiency and is an fascinating goal microscopy-based triage device for high-risk HPV-positive girls.

Grace's Media

CM021-320 20x500ml
EUR 340

Grace's Media

CM021-350 50x500ml
EUR 585

Grace's Media

CMP21-001 10x1L
EUR 159

Grace's Media

CMP21-010 10L
EUR 146

Grace's Media

CMP21-050 50L
EUR 336

FluorLast? Mounting Media

1213-20
EUR 142

NSC maintenance Media

ASE-9234SM 100 ml
EUR 131
Description: 18 month

Neuron Induction Media

ASE-9321NI 100 ml
EUR 131
Description: 18 month

Neuron Maturation Media

ASE-9321NM 100 ml
EUR 131
Description: 18 month

Astro Induction Media

ASE-9322AI 100 ml
EUR 131
Description: 18 month

Astro Maturation Media

ASE-9322AM 100 ml
EUR 131
Description: 18 month

DOPA Induction Media

ASE-9323DI 100 ml
EUR 147.2
Description: 18 month

DOPA Maturation Media

ASE-9323DM 100 ml
EUR 155.3
Description: 18 month

FBS Liquid Media

88-NB05 100 ml
EUR 164
Description: Fetal Bovine Serum (US origin)

FBS Liquid Media

88-NB06 500 ml
EUR 651
Description: FBS Liquid Media (Heat Inactivated)

Ceraplex Media 199

CCM37-050 500ml Ask for price

Endothelial Cryopreserve Media

FM300 10 ml
EUR 257

ENDO-Growth Media

MED001 500 ml
EUR 362

ENDO Basal Media

MED002 500 ml
EUR 207

YP BASE MEDIA

Y25-110-10kg 10 kg
EUR 899

YP BASE MEDIA

Y25-110-2kg 2kg
EUR 235

YP BASE MEDIA

Y25-110-500g 500 g
EUR 100

Human Chondrocytes Media

PC00B3 500 ml
EUR 362

Pericyte-Growth Media

PGB001 500 ml
EUR 297

Pericyte Basal Media

PGB002 475 ml
EUR 271

Astrocyte-Growth Media

PGB003 500 ml
EUR 297

Astrocyte Basal Media

PGB004 500 ml
EUR 271

Media 199 All-in-One Complete Media(10X), Singel quote

CAM37-005 50ml
EUR 246

MC-Easy Media Bonus Pack (includes Growth and Induction Media)

MN950A-1 5 preps
EUR 275

Dream Media Optimization Kit

184 Kit
EUR 162

Media Optimization Kit™

100 kit
EUR 122

ENDO-Growth Media Kit

EGK001 500 ml
EUR 362

Cell Freezing Media I

CA301-005 50ml
EUR 205

Cell Freezing Media II

CA302-005 50ml
EUR 228

Cell Freezing Media III

CA303-005 50ml
EUR 242

Leibovitz'a L-15 Media

CM030-050 500ml
EUR 84

Leibovitz'a L-15 Media

CM030-300 6x500ml
EUR 169

Leibovitz'a L-15 Media

CM030-310 10x500ml
EUR 203

Leibovitz'a L-15 Media

CM030-320 20x500ml
EUR 383

Leibovitz'a L-15 Media

CM030-350 50x500ml
EUR 690

Leibovitz'a L-15 Media

CM031-050 500ml
EUR 84

Leibovitz'a L-15 Media

CM031-300 6x500ml
EUR 169

Leibovitz'a L-15 Media

CM031-310 10x500ml
EUR 203

Leibovitz'a L-15 Media

CM031-320 20x500ml
EUR 383

Leibovitz'a L-15 Media

CM031-350 50x500ml
EUR 690

McCoy's 5A Media (Modified)

CM032-050 500ml
EUR 88

McCoy's 5A Media (Modified)

CM032-300 6x500ml
EUR 165

McCoy's 5A Media (Modified)

CM032-310 10x500ml
EUR 219

McCoy's 5A Media (Modified)

CM032-320 20x500ml
EUR 340

McCoy's 5A Media (Modified)

CM032-350 50x500ml
EUR 585

McCoy's 5A Media (Modified)

CM033-050 500ml
EUR 85

McCoy's 5A Media (Modified)

CM033-300 6x500ml
EUR 165

McCoy's 5A Media (Modified)

CM033-310 10x500ml
EUR 219

McCoy's 5A Media (Modified)

CM033-320 20x500ml
EUR 340

McCoy's 5A Media (Modified)

CM033-350 50x500ml
EUR 585

Buffered Glycerol Mounting Media

GMM003 3 ml
EUR 61

Buffered Glycerol Mounting Media

GMM030 30 ml
EUR 72

Buffered Glycerol Mounting Media

GMM500 500 ml
EUR 183

Buffered Glycerol Mounting Media

GMM999 1000 ml
EUR 260

Human BBB Model Media

NMBBB01 500 ml - Media
EUR 435

Permanent Mounting Media (Aqueous)

PMT030 30 ml
EUR 109

Permanent Mounting Media (Aqueous)

PMT999 1000 ml
EUR 759

Media Optimization Kit™, Liquid

128 kit
EUR 140

APF Media Optimization Kit™

0100-APF kit
EUR 122

CMRL 1066, CIT CULTURE MEDIA

98-304-CV 500 mL/pk
EUR 65
Description: Specialty Media; Islet products

Exosome-depleted FBS Media Supplement

EXO-FBS-250A-1 250 ml
EUR 881

Exosome-depleted FBS Media Supplement

EXO-FBS-50A-1 50 ml
EUR 241

Human IGF-I (Media Grade)

IM001 1 mg
EUR 624

Human IGF-I (Media Grade)

IM005 5 mg
EUR 161

Human IGF-I (Media Grade)

IU100 100 µg
EUR 327

ExoPure? Isolation Kit   (Cell Media)

K1237-10
EUR 664

ExoPure? Isolation Kit   (Cell Media)

K1237-2
EUR 392

Human L-EGF (Media Grade)

NM001 1 mg
EUR 438

Human L-EGF (Media Grade)

NM005 5 mg
EUR 717

Human IGF-II (Media Grade)

OM001 1 mg
EUR 902

Mouse ES Cell Culture Media

M16101 500 mL
EUR 1114

Rat Neurosphere-Progenitors Proliferation Media

M36111 500 ml
EUR 826

Human IGF-II (Media Grade)

OU100 100 µg
EUR 327

Pancreatic Stellate CAF Maintaining Media

PC00B5 500 ml
EUR 321

Michel's Transport Fluid

MTF-10000 10 L
EUR 762

Michel's Transport Fluid

MTF-20000 20 L
EUR 1340

Michel's Transport Fluid

MTF500 500 ml
EUR 98

Michel's Transport Fluid

MTF999 1000 ml
EUR 127

Dream Media Nutrient Mix, 5 packets

180 Pack 5
EUR 77

Dream Media Nutrient Mix, 100 ml

181 100 ml
EUR 71

APF Media Optimization Kit™, Liquid

129 kit
EUR 140

Freezing Media Pair™, 50 ml

406 50 ml
EUR 90

Grace's Supplemented Media (Hink's TNM-FH)

CM023-050 500ml
EUR 89

Grace's Supplemented Media (Hink's TNM-FH)

CM023-300 6x500ml
EUR 196

Grace's Supplemented Media (Hink's TNM-FH)

CM023-310 10x500ml
EUR 267

Grace's Supplemented Media (Hink's TNM-FH)

CM023-320 20x500ml
EUR 383

Grace's Supplemented Media (Hink's TNM-FH)

CM023-350 50x500ml
EUR 620

RPMI-1640 Media without L-glutamine

CM056-050 500ml
EUR 77

RPMI-1640 Media without L-glutamine

CM056-300 6x500ml
EUR 166

Every gynecologic cytology specimen examined by each a CT and a CP from December 2004 to March 2015 was extracted from the laboratory info system; glandular interpretations have been excluded. Excel and SAS have been used for CT-CP pair evaluation. CT-CP pairs with fewer than 32 specimens (the bottom quartile) have been excluded. For the remaining CT-CP pairs, 30 specimens or 10% of the specimens (whichever was greater) have been randomly chosen for comparability by a weighted κ statistic. κ values larger than 0.6 represented good settlement inside CT-CP pairs.

Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.

Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
To consider the prognostic influence of peritoneal washing cytology in sufferers with endometrial and ovarian cancers. We retrospectively recognized 86 people with ovarian carcinomas, ovarian borderline tumors and endometrial adenocarcinomas. The sufferers had been handled at Shahid Sadoughi Hospital and Ramazanzadeh Radiotherapy Center, Yazd, Iran between 2004 and 2012. Survival variations have been decided by Kaplan-Meier evaluation. Multivariate evaluation was carried out utilizing the Cox regression methodology. A p<0.05 value was thought of statistically vital.
There have been 36 sufferers with ovarian carcinomas, Four with borderline ovarian tumors and 46 with endometrial carcinomas. The imply age of the sufferers was 53.8±15.2 years. In sufferers with ovarian carcinoma the general survival in the adverse cytology group was higher than the sufferers with optimistic cytology though this distinction failed to achieve statistical significance (p=0.30). At Zero to 50 months the general survival was higher in sufferers with endometrial adenocarcinoma and adverse cytology than the sufferers with optimistic cytology however then it decreased (p=0.85).
At 15 to 60 months sufferers with FIGO 2009 stage IA-II endometrial andocarcinoma and adverse peritoneal cytology had a superior survival price in comparison with 1988 IIIA and optimistic cytology solely, though this distinction failed to achieve statistical significance(p=0.94). Multivariate evaluation utilizing Cox proportional hazards mannequin confirmed that stage and peritoneal cytology have been predictors of loss of life.

Diagnostic value of HMGB1 immunostaining on cell blocks from residual liquid-based gynecologic cytology specimens.

Aberrant expression of excessive mobility group field 1 (HMGB1) is related to tumor improvement and development. The present examine was carried out to guage the importance of HMGB1 immunostaining on cell block (CB) preparations in the analysis of neoplastic and preneoplastic lesions of the cervix. The CBs have been ready from 157 residual liquid-based gynecologic cytology specimens which have been collected from ladies whose cervical lesions had been confirmed by histopathology.

The expression of HMGB1 and p16INK4A (p16) was visualized by immunocytochemistry on the CB preparations, and the affiliation of their expression patterns was correlated with the severity of cervical lesions. HeLa cells have been used as optimistic management. HMGB1 expression was noticed in dysplastic and neoplastic cells and elevated together with the development of cervical neoplasia.

The charges of optimistic staining for HMGB1 in cervical intraepithelial neoplasia 1 (CIN-1), CIN-2, CIN-3, and invasive squamous cell carcinomas (ISCCs) have been 69.4, 96.9, 100.0, and 100.0%, respectively. The variations between optimistic charges of sufferers with persistent cervicitis and numerous CINs in addition to ISCCs have been vital (P < 0.005).

The variations in optimistic staining charges between every two CIN teams, and variations between CIN-1\/2 and ISCCs, have been additionally vital (P < 0.005). The expression sample of HMGB1 was typically correlated with that of p16 (P < 0.001). HMGB1 staining was noticed in some p16-negative specimens. HMGB1 immunostaining on a CB from gynecologic cytology specimens is doubtlessly useful for the screening of cervical lesions in instances with questionable cytology.

We in contrast cytotechnologists’ efficiency and reproducibility of guide and automatic screening of 10,165 consecutive cervical cytology slides examined at Barretos Cancer Hospital utilizing the FocalPoint system. In whole, 83% of atypical squamous cells of undetermined significance and higher have been categorized as quintiles 1 and a couple of; no high-grade squamous intraepithelial lesions and higher have been noticed in quintile 5.
No statistically vital variations have been discovered between guide and automatic screening, utilizing cervical biopsy specimens because the gold customary. Our outcomes present good correlation of peritoneal cytology with prognosis in sufferers with ovarian carcinoma. In endometrial carcinoma it had prognostic significance. Additional analysis is warranted.
Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.

Optimal z-axis scanning parameters for gynecologic cytology specimens.

The use of digital microscopy (VM) in scientific cytology has been restricted as a result of incapacity to focus via three dimensional (3D) cell clusters with a single focal aircraft (2D photos). Limited data exists concerning the optimum scanning parameters for 3D scanning. The function of this examine was to find out the optimum quantity of the focal aircraft ranges and the optimum scanning interval to digitize gynecological (GYN) specimens ready on SurePath™ glass slides whereas sustaining a manageable file measurement.
The iScanCoreo Au scanner (Ventana, AZ, USA) was used to digitize 192 SurePath™ glass slides at three focal aircraft ranges at 1 μ interval. The digitized digital photos (VI) have been annotated utilizing BioImagene’s Image Viewer. Five individuals interpreted the VI and recorded the focal aircraft stage at which they felt assured and later interpreted the corresponding glass slide specimens utilizing mild microscopy (LM). The individuals accomplished a survey about their experiences. Inter-rater settlement and concordance between the VI and the glass slide specimens have been evaluated.

96 Well Lung Tumor Genomic DNA Plate

D8235152-1 1 plate
EUR 316

Human Genomic DNA

BIO-35025 500µl @ 200ng/µl Ask for price

Human Genomic DNA

X11000 0.2 ml Ask for price
Description: reagents widely cited

Genomic DNA - Human Diabetic Tissue: Lung, from a single donor

D1236152Dia 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Asthma: Lung, from a single donor

D1236152Ld-1 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Bronchitis: Lung, from a single donor

D1236152Ld-2 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Emphysema: Lung, from a single donor

D1236152Ld-3 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Pneumonia: Lung, from a single donor

D1236152Ld-4 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Lupus: Lung, from a single donor

D1236152Lup 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Human Male

D1234999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Human Female

D1234999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Human Brain Genomic DNA

X11001 10 µg Ask for price
Description: kits suitable for this type of research

FFPE and Frozen Matching Pair Genomic DNA: Human Tumor Tissue: Lung

D8235152-FP 2 x 2 ug
EUR 1957
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA Kit

20-abx098076
  • EUR 439.00
  • EUR 244.00
  • 200 rxns
  • 50 rxns

Genomic DNA from Liver Cirrhosis: Lung, from a single donor

D1236152Lcs 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Pulmonary embolism: Lung, from a single donor

D1236152Ld-5 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Human Adult Normal Tissue: Lung, from a single donor

D1234152 100 ug
EUR 282
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA from Human Tumor Tissue: Lung Tumor, from a single donor

D1235152 50 ug
EUR 446
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA Isolation Kit

55R-1362 50 assays
EUR 385
Description: Genomic DNA Isolation Kit for use in the research laboratory

Genomic DNA - Mouse Male

D1334999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Mouse Female

D1334999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rat Male

D1434999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rat Female

D1434999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Dog Male

D1734999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Dog Female

D1734999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rabbit Male

D1834999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rabbit Female

D1834999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Porcine Male

D1934999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Porcine Female

D1934999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Bovine Male

D1B34999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Bovine Female

D1B34999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Chicken Male

D1C34999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Chicken Female

D1C34999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Hamster Male

D1H34999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Hamster Female

D1H34999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Horse Male

D1O34999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Horse Female

D1O34999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Plant Genomic DNA Kit

20-abx098077
  • EUR 411.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Bacteria Genomic DNA Kit

20-abx098080
  • EUR 105.00
  • EUR 244.00
  • 2 rxns
  • 50 rxns

Micro Genomic DNA Kit

20-abx098242
  • EUR 105.00
  • EUR 328.00
  • 2 rxns
  • 50 rxns

Blood Genomic DNA Kit

abx098868-50rxns 50 rxns
EUR 272

Plant Genomic DNA Kit

abx294004-50preps 50 preps
EUR 398

Animal Genomic DNA Kit

abx294005-100preps 100 preps
EUR 523

Animal Genomic DNA Kit

abx294005-50preps 50 preps
EUR 398

Genomic DNA Extraction Kit

K5016005 1 kit
EUR 329

Genomic DNA Isolation Kit

K281-50
EUR 272

Genomic DNA Isolation Kit

K2118-50 50 assays
EUR 321

Soil Genomic DNA Kit

K1411-250
EUR 561

Soil Genomic DNA Kit

K1411-50
EUR 316

Insect Genomic DNA Kit

K1412-250
EUR 561

Insect Genomic DNA Kit

K1412-50
EUR 316

Mollusc Genomic DNA Kit

K1413-250
EUR 561

Mollusc Genomic DNA Kit

K1413-50
EUR 316

Yeast Genomic DNA Kit

K1414-250
EUR 561

Yeast Genomic DNA Kit

K1414-50
EUR 316

Fungal Genomic DNA Kit

K1415-250
EUR 561

Fungal Genomic DNA Kit

K1415-50
EUR 316

Fully CpG Methylated Human Genomic DNA

X10000 10 µg/100 µl Ask for price
Description: The best epigenetics products

Genomic DNA - Cynomolgus Monkey Male

D1534999-Cy-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Cynomolgus Monkey Female

D1534999-Cy-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rhesus Monkey Male

D1534999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Rhesus Monkey Female

D1534999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Guinea Pig Male

D1G34999-G01 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Genomic DNA - Guinea Pig Female

D1G34999-G02 100 ug
EUR 188
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Plant Genomic DNA extraction buffer

20-abx098075
  • EUR 286.00
  • EUR 105.00
  • 100 ml
  • 1.2 ml

Marine Animal Genomic DNA Kit

20-abx098079
  • EUR 105.00
  • EUR 244.00
  • 2 rxns
  • 50 rxns

FFPE Tissue Genomic DNA Kit

abx098866-50rxns 50 rxns
EUR 272

ISOLATE II Genomic DNA Kit

BIO-52065 10 preps Ask for price

ISOLATE II Genomic DNA Kit

BIO-52066 50 preps Ask for price

ISOLATE II Genomic DNA Kit

BIO-52067 250 preps Ask for price

Genomic DNA Extraction KitAnimal Tissue

FYG102-100P 100 Preps Ask for price

Genomic DNA Extraction KitAnimal Tissue

FYG102-300P 300 Preps Ask for price

Genomic DNA Extraction KitAnimal Tissue

FYG102-50P 50 Preps Ask for price

Genomic DNA Extraction Maxi KitPlant

FYG104-10P 10 Preps Ask for price

Genomic DNA Extraction Maxi KitPlant

FYG104-25P 25 Preps Ask for price

AccuRT Genomic DNA Removal Kit

G488 200 Reactions
EUR 82

Genomic DNA Extraction and Purification

EP10012 100 Tests
EUR 505

Bacterial Genomic DNA Isolation Kit

K309-100
EUR 376

Zenoquick Genomic DNA Purification Kit

Z2003-200 200 preps
EUR 631

Zenoprep Genomic DNA Purification Kit

Z2004-400 400 preps
EUR 550

FFPE Genomic DNA - Human Tumor Tissue: Breast

D2235086 2 ug
EUR 821
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

FFPE Genomic DNA - Human Tumor Tissue: Colon

D2235090 2 ug
EUR 821
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

FFPE Genomic DNA - Human Tumor Tissue: Pancreas

D2235188 2 ug
EUR 821
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

FFPE Genomic DNA - Human Tumor Tissue: Stomach

D2235248 2 ug
EUR 821
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

FFPE Genomic DNA - Human Tumor Tissue: Uterus

D2235274 2 ug
EUR 821
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

100 BP DNA LADDER, 500UL PER KIT

M-DNA-100BP 1/pk
EUR 73
Description: Bioscience Mol Bio; DNA Ladder

1 KB DNA LADDER, 500UL PER KIT

M-DNA-1KB 1/pk
EUR 70
Description: Bioscience Mol Bio; DNA Ladder

Genomic DNA Kit (No RNase A)

20-abx098862
  • EUR 398.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Genomic DNA Extraction Mini KitPlant Tissue

FYG103-100P 100 Preps Ask for price

Easy3-Plant Genomic DNA Isolation Kit

FYG503-100P 100 Preps Ask for price

Easy3-Plant Genomic DNA Isolation Kit

FYG503-500P 500 Preps Ask for price

Mammalian Cell Genomic DNA Isolation Kit

K967-100
EUR 381

Plant Tissue Genomic DNA Isolation Kit

K316-100
EUR 376

Rapid Animal Genomic DNA Extraction Kit

AT4780 10Preps
EUR 69.03

Rapid Animal Genomic DNA Extraction Kit

AT4781 50Preps
EUR 126.13

Rapid Animal Genomic DNA Extraction Kit

AT4782 250preps
EUR 354.5
This examine decided an total excessive intra-rater diagnostic concordance between glass and VI (89-97%), nonetheless, the inter-rater settlement for all instances was larger for LM (94%) in contrast with VM (82%). Survey outcomes point out individuals discovered low grade dysplasia and koilocytes straightforward to diagnose utilizing three focal aircraft ranges
the picture enhancement software was helpful and focusing via the cells helped with interpretation; nonetheless, the individuals discovered VI with hyperchromatic crowded teams difficult to interpret. Participants reported they like utilizing LM over VM. This examine helps utilizing three focal aircraft ranges and 1 μ interval to develop the use of VM in GYN cytology. Future enhancements in expertise and acceptable coaching ought to make this format a extra preferable and sensible possibility in scientific cytology.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

Liquid-based preparations (LBPs) have largely changed conventional Papanicolaou smears (CPS) for cervical samples within the United States and in lots of different industrialized international locations. The two FDA-approved LBP at present in use embody ThinPrep (TP), (Hologic Inc., Bedford, MA) and SurePath (SP), (BD Diagnostic, Burlington, NC). Split-sample and direct-to-vial research have proven that LBPs present an general enchancment in pattern assortment and processing

scale back artifacts that intrude in prognosis, are extra delicate, might be utilized for ancillary checks and are a cost-effective alternative for CPS. Comparative analyses of diagnostic accuracy point out that LBPs carry out a minimum of in addition to CPS. However, the added benefits of standardized, automated preparations and screening, lowered unsatisfactory fee, improved specimen adequacy and means to carry out human papillomavirus (HPV) check, are sufficient to proceed use of LBP. The cytologic options in LBP are just like CPS with refined variations, notably in background info.

There are additionally refined variations between the 2 LBPs, SP and TP, that are reflective of completely different sampling gadgets, assortment media, and processing methods. Architecturally, LBP exhibits smaller cell clusters and sheets and extra dyscohesion. Cytologically, enhanced nuclear options and smaller cell measurement are extra distinguished.

Advances in liquid-based Papanicolaou’s (Pap) check have result in well-defined affected person administration tips by the American Society for Colposcopy and Cervical Pathology. Herein, we review these features of Pap check together with, morphology, automation, ancillary checks (HPV and immunochemistry), pertinent QA/QC screens, affected person administration tips, and review of pertinent literature.

After an intense interval of laboratory coaching, a cohort of 10,233 present and seeded irregular slides have been labeled initially by FPGS. Manual screening and reclassification blinded to the FPGS outcomes have been then carried out. Any adequacy and/or cytodiagnostic discrepancy between the two screening strategies subsequently was resolved by way of a consensus course of (fact).

The efficiency of every technique’s adequacy and cytodiagnosis vis-a-vis the reality was established. The sensitivity and specificity of every technique at Four cytodiagnostic thresholds (atypical squamous cells of undetermined significance or worse [ASC-US+], low-grade squamous intraepithelial lesion or worse [LSIL+], high-grade squamous intraepithelial lesion or worse [HSIL+], and carcinoma) have been in contrast. The false-negative fee for every cytodiagnosis was decided.

Assessment of handbook workload limits in gynecologic cytology: reconciling knowledge from Three main potential trials of automated screening gadgets.

Previous potential research have proven completely different outcomes when evaluating automated and handbook screening of gynecologic cytology. The outcomes of Three massive potential research have been reviewed and relative sensitivity used as a gold normal. No vital variations could possibly be proven in relative sensitivity between the ThinPrep Imaging System and the FocalPoint GS Imaging System (P>> .05). When handbook screening was restricted to lower than 6 hours per day

50 or fewer slides per day, and a minimum of 6 minutes per slide (<10 slides/h), the relative sensitivity for automation was considerably decrease for atypical squamous cells of undetermined significance and above (ASC+) (0.81; 95% confidence interval [CI], 0.79-0.83) than when handbook screening was not restricted (1.07; 95% CI, 1.03-1.10).

All Three websites that screened 10 or extra slides per hour manually had a relative sensitivity for automation that was considerably increased for high-grade squamous intraepithelial lesions and above (HSIL+) than for the remaining teams who screened lower than 10 slides per hour (1.40 [95% CI, 1.22-1.60] vs 0.97 [95% CI, 0.95-1.00]). These outcomes recommend that location discovering of abnormalities (ASC+) could also be extra strongly related to time spent screening per day,

whereas classification/interpretation expertise (HSIL+) could rely on time spent on a person case. There is not any proof that automated screening gadgets are extra delicate than handbook screening carried out at decrease well-defined workloads. More restricted workloads (≤41 slides/d, ≤4.5 h/d) for handbook screening could carry out considerably higher than automated screening gadgets as measured by histologic cervical intraepithelial neoplasia 2 and above.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

The function of monitoring interpretive charges, concordance between cytotechnologist and pathologist interpretations earlier than sign-out, and turnaround time in gynecologic cytology high quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 1.

The College of American Pathologists (CAP) performed a nationwide survey of gynecologic cytology high quality assurance (QA) practices. Experts in gynecologic cytology have been requested to affix 5 working teams that studied the survey knowledge on completely different features of QA. Evaluating the survey knowledge and follow-up questions on-line, along with a review of pertinent literature, the working teams developed a collection of preliminary statements on good laboratory practices in cytology QA. These have been offered at a consensus convention and digital voting occurred.
To consider a set of QA screens in gynecologic cytology. Working group 1 evaluated (1) monitoring interpretive fee classes for Papanicolaou checks (Pap checks), (2) concordance of cytotechnologist and pathologist interpretations earlier than sign-out, and (3) turnaround time for Pap checks. The statements are primarily based on a survey of gynecologic cytology QA observe patterns and of opinions from working group members and consensus convention attendees.

cDNA from Emphysema: Lung

C1236152Ld-3 40 reactions
EUR 811
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Pneumonia: Lung

C1236152Ld-4 40 reactions
EUR 811
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Lupus: Lung

C1236152Lup 40 reactions
EUR 668
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Liver Cirrhosis: Lung

C1236152Lcs 40 reactions
EUR 668
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Pulmonary Embolism: Lung

C1236152Ld-5 40 reactions
EUR 811
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Human Adult cDNA Tissue: Lung

HA-152 10 rxn
EUR 415

cDNA from Human Tumor Tissue: Lung

C1235152 40 reactions
EUR 540
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Diabetic Tissue: Lung

C1236152Dia 40 reactions
EUR 668
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Mouse Normal Tissue: Lung

C1334152 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Rat Normal Tissue: Lung

C1434152 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Dog Normal Tissue: Lung

C1734152 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung

C1234152 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Monkey (Rhesus) Normal Tissue: Lung

C1534152 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Monkey (Cynomolgus) Normal Tissue: Lung

C1534152-Cy 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung: Left Lower Lobe

C1234155 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung: Left Upper Lobe

C1234156 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung: Right Lower Lobe

C1234157 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung: Right Middle Lobe

C1234158 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

cDNA from Human Adult Normal Tissue: Lung: Right Upper Lobe

C1234159 40 reactions
EUR 376
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Matching Pair - cDNA from Human Primary Tumor and Normal Tissue: Lung

C8235152-PP 10 reactions x2
EUR 499
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Matching Pair - cDNA from Human Primary and Matched Metastatic Tumor Tissue: Lung

C8235152-PM 10 reactions x2
EUR 984
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes.

Hamster IgM

31C-CH0707 1 mg
EUR 410
Description: Purified Hamster IgM

Hamster Mono Anti-Mouse CD3e IgG (Hamster IgG)

MCD003E-M 100 Tests
EUR 482

Hamster Mono Anti-Mouse CD3z IgG (Hamster IgG)

MCD003Z-M 100 ug
EUR 482

Mouse Lung PrimaCell2: Normal Lung Fibroblasts

2-82065 1 Kit Ask for price

Rat Lung PrimaCell1: Normal Lung Fibroblasts

2-82564 1 Kit Ask for price

Human Lung PrimaCell1: Normal Lung Fibroblasts

2-96081 1 Kit Ask for price

Hamster Lymphocyte antibody

20R-LR011 20 mg